JAADRCT
Dupilumab treatment improves linear growth and bone biomarkers in children with atopic dermatitis
Post hoc analysis of a phase 3 randomized, placebo-controlled clinical trial and an open-label extension study.
ConclusionDupilumab treatment in children with AD was associated with height and BALP level improvements.
Irvine AD, Paller AS, … senior author Cyr SLJournal of the American Academy of Dermatology